Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …

Background People living with HIV are at an increased risk of fatal outcome when admitted
to hospital for severe COVID-19 compared with HIV-negative individuals. We aimed to …

Background There is a paucity of data on COVID-19 vaccines in people living with HIV-1,
who could be at increased risk of severe illness and death from COVID-19. We evaluated the …

Background Assessing safety and efficacy of Covid-19 vaccines in different populations is
essential, as is investigation of efficacy against emerging SARS-CoV-2 variants of concern …

Coronavirus disease 2019 (COVID-19) is a public health emergency of international concern
1. People living with HIV (PLWH) are at increased risk for adverse COVID-19 outcomes …

Background The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …

COVID-19 vaccine efficacy (VE) has been observed to vary against antigenically distinct
SARS-CoV-2 variants of concern (VoC). Here we report the final analysis of VE and safety from …

… Born in 1921 in Krefeld, Germany; Joseph Beuys initially decided to study medicine, then …
The fundamental purpose of this study is to examine the works of Joseph Beuys as an example …

In this South African phase 1/2b study, we demonstrated vaccine efficacy (VE) of two doses
of AZD1222 for asymptomatic and symptomatic SARS-CoV-2 infection: 90.6% against wild-…

OBJECTIVE: To determine whether the prevalence of gout and/or clinically significant
hyperuricemia increased in a managed care population over 10 years. METHODS: The study was …